-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PduZuU+RtFS2vWBHFr8pHYvzoVuLn39O9PaGj2VGESPi7Ux+VaSK4/y5E8HopeBC R5ACli1tUUFD23KXYgUvlA== 0001140361-10-000551.txt : 20100105 0001140361-10-000551.hdr.sgml : 20100105 20100105160216 ACCESSION NUMBER: 0001140361-10-000551 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100101 FILED AS OF DATE: 20100105 DATE AS OF CHANGE: 20100105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chouinard Michel CENTRAL INDEX KEY: 0001479927 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 10506767 MAIL ADDRESS: STREET 1: CORAL SANDS RESORT STREET 2: SUITE 501 CITY: WORTHING, CHRIST CHURCH STATE: C8 ZIP: BB17154 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVAIL CORP INTERNATIONAL CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 905 286-3000 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 3 1 doc1.xml FORM 3 X0203 3 2010-01-01 0 0000885590 BIOVAIL CORP INTERNATIONAL BVF 0001479927 Chouinard Michel C/O BIOVAIL CORPORATION, 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 0 1 0 0 COO, Biovail Labs. Int'l SRL Common Stock, no par value 2470 D Stock Options (right to purchase) 16.97 2010-03-15 Common Stock, no par value 2000 D Stock Options (right to purchase) 24.51 2011-03-30 Common Stock, no par value 8000 D Stock Options (right to purchase) 22.05 2012-03-22 Common Stock, no par value 32250 D Restricted Share Units 2011-03-12 2011-03-12 Common Stock, no par value 3744 D Stock Options (right to purchase) 10.83 2013-04-01 Common Stock, no par value 25000 D Restricted Share Units 2012-02-25 2012-02-25 Common Stock, no par value 4588 D Stock Options (right to purchase) 10.86 2014-03-09 Common Stock, no par value 12988 D Stock Options (right to purchase) 10.86 2014-03-09 Common Stock, no par value 52500 D Restricted Share Units 2014-08-05 2014-08-05 Common Stock, no par value 50306 D On March 15, 2005, the Reporting Person was granted Stock Options, all of which are currently exercisable. Converted from Cdn. $20.50 using the Bank of Canada exchange rate of $0.8280 (exchange rate on the grant date). On March 30, 2006, the Reporting Person was granted 8,000 Stock Options, all of which are currently exercisable. Converted from Cdn. $28.50 using the Bank of Canada exchange rate of $0.8601 (exchange rate on the grant date). On March 22, 2007, the Reporting Person was granted Stock Options, of which 21,500 Stock Options are currently exercisable. The remaining 10,750 Stock Options will vest and become exercisable on March 1, 2010. Includes an initial grant of 3,125 Restricted Share Units (granted on March 12, 2008) and additional Restricted Share Units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock, no par value, of Biovail Corporation (the "Common Stock"). Each Restricted Share Unit represents a contingent right to receive one share of Common Stock. On April 1, 2008, the Reporting Person was granted Stock Options. 12,500 Stock Options will vest and become exercisable on each of April 1, 2010 and 2011. Includes an initial grant of 4,375 Restricted Share Units (granted on February 25, 2009) and additional Restricted Share Units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock. On March 9, 2009, the Reporting Person was granted 12,988 Stock Options. 4,329 Stock Options will vest and become exercisable on each of March 9, 2010 and 2011 and the remaining 4,330 Stock Options will vest and become exercisable on March 9, 2012. On March 9, 2009, the Reporting Person was granted 52,500 Stock Options, which will vest and become exercisable in three equal annual installments commencing on the first anniversary of the grant date. Includes an initial grant of 50,000 performance based Restricted Share Units (granted on August 5, 2009) and additional Restricted Share Units that were allocated to the Reporting Person as dividend equivalents on the payment date(s) of dividends on Common Stock. See Exhibit 24.1 - Power of Attorney /s/ Angie Palmer, by Power of Attorney 2010-01-05 EX-24.1 2 poa1.htm POWER OF ATTORNEY Unassociated Document
 
 
POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes and appoints each of Gregory Gubitz, Jennifer Tindale, Michael Krushel, Alex Matheson, Jennifer Suess, Christopher Hall, Angie Palmer and Michelle Garraway, or any of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

 
(1)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) or any rule or regulation of the SEC;

 
(2)
execute for and on behalf of the undersigned, in the undersigned's capacity as an officer of Biovail Corporation (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Exchange Act and the rules thereunder;

 
(3)
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and
 
 
(4)
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
 
 

 
 

 
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 4th day of January, 2010.

 
 
 
    /s/ Michel Chouinard  
Signature
 
 
    Michel Chouinard   
Name

-----END PRIVACY-ENHANCED MESSAGE-----